Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.3.1345

Methylenetetrahydrofolate Reductase Polymorphisms and Susceptibility to Esophageal Cancer in Chinese Populations: a Meta-analysis  

Yang, Yong-Bin (Health Science Center, Hebei University)
Shang, Yan-Hong (Affiliated Hospital of Hebei University)
Tan, Yan-Li (Health Science Center, Hebei University)
Kang, Xian-Jiang (College of Life Sciences, Hebei University)
Meng, Ming (Health Science Center, Hebei University)
Zhao, Zhan-Xue (Health Science Center, Hebei University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1345-1349 More about this Journal
Abstract
Although many epidemiologic studies investigated the methylenetetrahydrofolate reductase (MTHFR) polymorphisms and their associations with esophageal cancer, definite conclusions could not be drawn. To clarify the effects of MTHFR polymorphisms on the risk of esophageal cancer, a meta-analysis was here performed in Chinese populations. A total of 16 studies including 3,040 cases and 4,127 controls were involved in this metaanalysis. Overall, significant associations were found between the MTHFR C677T polymorphism and esophageal cancer risk when all studies in Chinese populations were pooled into the meta-analysis (T vs. C, OR = 1.19, 95% CI = 1.06-1.34; TT vs. CC, OR = 1.35, 95% CI = 1.07-1.70; TT+ CT vs. CC, OR = 1.29, 95% CI = 1.08-1.54; TT vs. CC + CT, OR = 1.19, 95% CI = 1.03-1.37). In subgroup analyses stratified by ethnicity and source of controls, the same results were found in Kazakh (TT vs. CC, OR = 1.38, 95% CI = 1.02-1.87; TT + CT vs. CC, OR = 1.50, 95% CI = 1.03-2.18), in not stated populations (T vs. C, OR = 1.24, 95% CI = 1.08-1.42; TT vs. CC, OR = 1.47, 95% CI = 1.10-1.96; TT + CT vs. CC, OR = 1.30, 95% CI = 1.05-1.60; TT vs. CC + CT, OR = 1.32, 95% CI = 1.12-1.56), and in hospital-based studies (T vs. C, OR = 1.34, 95% CI = 1.19-1.51; TT vs. CC, OR = 1.81, 95% CI = 1.37-2.39; TT + CT vs. CC, OR = 1.51, 95% CI = 1.26-1.83; and TT vs. CC + CT, OR = 1.39, 95% CI = 1.13-1.70). In conclusion, this meta-analysis provides evidence that the MTHFR C677T polymorphism contributes to esophageal cancer development in Chinese populations.
Keywords
Meta-analysis; methylenetetrahydrofolate reductase; polymorphism; esophageal cancer;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Zacho J, Yazdanyar S, Bojesen SE, et al (2011). Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75, 000 cases and 93, 000 controls. Int J Cancer, 128, 644-52.   DOI   ScienceOn
2 Zhang JF, Pang LJ, Zhao J, et al (2006). Association of methylenetetrahydrofolate reductase C677T polymorphism with susceptibility to esophageal caner in Kazakh and Han populations in Xinjiang Uygur Autonomous Region. World Chin J Digestol, 14, 1475-80 (in Chinese).
3 Zhang LW, Ilyar Sheyhidin, Wu MB, et al (2008). Study on relationship between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of Kazakh's esophageal cancer in Xinjiang. Chin J Cancer Prev Treat, 15, 1294-7 (in Chinese).
4 Zhang ZF, Kurtz RC, Yu GP, et al (1997). Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer, 27, 298-309.   DOI   ScienceOn
5 Zhao P, Lin F, Li Z, et al (2011). Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer. Asian Pac J Cancer Prev, 12, 2019-23.
6 Wang Q, Li D, Ye WJ, et al (2009). Effect of MTHFR C677T mutation, interaction between MTHFR C677T mutation and environm ental factors on esophageal cancer. Chin J Public Health, 25, 1308-10 (in Chinese).
7 Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
8 Tan X, Wang YY, Dai L, et al (2013). Genetic polymorphism of MTHFR A1298C and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 14, 1951-5.   과학기술학회마을   DOI   ScienceOn
9 Wang LD, Guo RF, Fan ZM, et al (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.   DOI   ScienceOn
10 Wang Y, Guo W, He Y, et al (2007). Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control, 18, 143-52.   DOI   ScienceOn
11 Li QD, Li H, Wang MS, et al (2011). Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County. BMC Gastroenterol, 11, 74.   DOI
12 Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.   DOI   ScienceOn
13 Wen YY, Yang SJ, Zhang JX, et al (2013). Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 21-5.   과학기술학회마을   DOI   ScienceOn
14 Wu JZ, Gao CM, Ding JH, et al (2002). Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of esophageal cancer. Tumor, 22, 268-70 (in Chinese).
15 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
16 Kim YI (2000). Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev, 58, 205-9.
17 Langevin SM, Lin D, Matsuo K, et al (2009). Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett, 184, 73-80.   DOI   ScienceOn
18 Lin Y, Totsuka Y, He Y, et al (2013). Epidemiology of esophageal cancer in Japan and China. J Epidemiol, 23, 233-42.   DOI
19 Liu YX, Wang B, Wan MH, et al (2011). Meta-analysis of the relationship between the metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev, 12, 247-52.
20 Qin JM, Yang L, Chen B, et al (2008). Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol, 14, 6986-92.   DOI   ScienceOn
21 Qu HH, Cui LH, Wang K, et al (2013). The methylenetetrahydrofolate reductase C677T polymorphism influences risk of esophageal cancer in Chinese. Asian Pac J Cancer Prev, 14, 3163-8.   과학기술학회마을   DOI   ScienceOn
22 Song C, Xing D, Tan W, et al (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
23 Fang Y, Xiao F, An Z, et al (2011). Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 1861-6.
24 Cai JF, Qin JM, Liao PH, et al (2011). Value of detection of HLA, other immune-related genes and MTHFR in the screening of esophageal cancer in Xinjiang Kazakh population. World Chin J Digestol, 19, 2572-6 (in Chinese).
25 Chang-Claude JC, Wahrendorf J, Liang QS, et al (1990). An epidemiological study of precursor lesions of esophageal cancer among young persons in a high risk population in Huixian, China. Cancer Res, 50, 2268-74.
26 Chen Y, Yin D, Deng YC, et al (2009). Relationship between MTHFR gene polymorphisms and susceptibility of esophageal cancer of Han nationality in Xinjiang. J Toxicol (in Chinese), 23, 429-32.
27 Friedman G, Goldschmidt N, Friedlander Y, et al (1999). A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr, 129, 1656-61.
28 Hu J, Nyren O, Wolk A, et al (1994). Risk factors for oesophageal cancer in northeast China. Int J Cancer, 57, 38-46.
29 Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.   DOI   ScienceOn
30 Gao CM, Toshiro T, Wu JZ, et al (2004). A case-control study on the polymorphisms of methylenetetrahydrofolate reductase 1298A-->C and susceptibility of esophageal cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 25, 341-5 (in Chinese).
31 Yang JB, Shen YW, Zeng M, et al (2012). Relationship between MTHFR C677T polymorphisms and susceptibility of esophageal cancer in north Sichuan population. Sichuan Med, 33, 26-7 (in Chinese).